Susquehanna International Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.6M Sell
154,100
-135,700
-47% -$33.8M ﹤0.01% 1596
2025
Q4
$69.8M Buy
289,800
+63,700
+28% +$16.3M 0.01% 1114
2025
Q3
$61.9M Buy
226,100
+45,000
+25% +$12.3M 0.01% 1197
2025
Q2
$46.7M Sell
181,100
-6,700
-4% -$1.6M 0.01% 1219
2025
Q1
$42M Sell
187,800
-56,200
-23% -$13.1M 0.01% 1131
2024
Q4
$55.8M Sell
244,000
-89,400
-27% -$21.5M 0.01% 1033
2024
Q3
$81.4M Buy
333,400
+163,000
+96% +$36.4M 0.01% 764
2024
Q2
$32.6M Buy
170,400
+16,500
+11% +$3.35M 0.01% 1291
2024
Q1
$30.5M Sell
153,900
-9,100
-6% -$1.67M 0.01% 1393
2023
Q4
$28M Buy
163,000
+65,300
+67% +$10M 0.01% 1460
2023
Q3
$14.4M Buy
97,700
+73,500
+304% +$13.3M ﹤0.01% 2112
2023
Q2
$5.29M Buy
24,200
+7,200
+42% +$1.6M ﹤0.01% 3433
2023
Q1
$3.72M Sell
17,000
-12,100
-42% -$2.63M ﹤0.01% 3902
2022
Q4
$6.06M Buy
29,100
+12,200
+72% +$2.68M ﹤0.01% 2944
2022
Q3
$3.69M Buy
16,900
+5,000
+42% +$1.14M ﹤0.01% 3678
2022
Q2
$2.5M Sell
11,900
-9,600
-45% -$2.04M ﹤0.01% 4439
2022
Q1
$5.21M Sell
21,500
-800
-4% -$194K ﹤0.01% 3573
2021
Q4
$5.81M Sell
22,300
-23,400
-51% -$6.07M ﹤0.01% 3496
2021
Q3
$12M Buy
45,700
+32,000
+234% +$8.75M ﹤0.01% 2604
2021
Q2
$3.38M Buy
13,700
+3,800
+38% +$799K ﹤0.01% 4773
2021
Q1
$1.92M Sell
9,900
-17,100
-63% -$3.43M ﹤0.01% 6028
2020
Q4
$5.74M Sell
27,000
-18,100
-40% -$3.61M ﹤0.01% 3212
2020
Q3
$7.73M Buy
45,100
+17,700
+65% +$3.27M ﹤0.01% 2505
2020
Q2
$5.26M Sell
27,400
-11,800
-30% -$1.93M ﹤0.01% 2940
2020
Q1
$5.77M Buy
39,200
+31,800
+430% +$5.07M ﹤0.01% 2400
2019
Q4
$1.15M Sell
7,400
-1,000
-12% -$144K ﹤0.01% 5268
2019
Q3
$1.14M Sell
8,400
-13,700
-62% -$1.79M ﹤0.01% 5425
2019
Q2
$2.7M Sell
22,100
-20,700
-48% -$2.29M ﹤0.01% 3633
2019
Q1
$4.45M Sell
42,800
-110,900
-72% -$11.4M ﹤0.01% 2595
2018
Q4
$17.5M Buy
153,700
+98,600
+179% +$10.6M 0.01% 1161
2018
Q3
$6.36M Sell
55,100
-7,900
-13% -$865K ﹤0.01% 2392
2018
Q2
$6.53M Buy
63,000
+28,100
+81% +$2.84M ﹤0.01% 2419
2018
Q1
$3.44M Buy
34,900
+17,500
+101% +$1.65M ﹤0.01% 3043
2017
Q4
$1.47M Buy
17,400
+4,900
+39% +$405K ﹤0.01% 4494
2017
Q3
$962K Sell
12,500
-2,600
-17% -$199K ﹤0.01% 5345
2017
Q2
$1.18M Sell
15,100
-17,300
-53% -$1.24M ﹤0.01% 4928
2017
Q1
$2.33M Buy
32,400
+19,800
+157% +$1.37M ﹤0.01% 3432
2016
Q4
$782K Sell
12,600
-183,300
-94% -$11.2M ﹤0.01% 6039
2016
Q3
$12.7M Buy
195,900
+68,900
+54% +$4.59M 0.01% 1347
2016
Q2
$8.03M Buy
127,000
+78,400
+161% +$4.62M ﹤0.01% 1651
2016
Q1
$2.81M Sell
48,600
-12,000
-20% -$679K ﹤0.01% 3162
2015
Q4
$3.25M Sell
60,600
-100,000
-62% -$5.64M ﹤0.01% 3142
2015
Q3
$8.18M Sell
160,600
-2,700
-2% -$145K ﹤0.01% 2061
2015
Q2
$9.21M Buy
163,300
+104,800
+179% +$6.61M ﹤0.01% 2103
2015
Q1
$4.2M Buy
58,500
+6,000
+11% +$390K ﹤0.01% 2996
2014
Q4
$2.94M Sell
52,500
-3,200
-6% -$167K ﹤0.01% 3775
2014
Q3
$2.74M Sell
55,700
-109,300
-66% -$5.57M ﹤0.01% 4059
2014
Q2
$8.35M Sell
165,000
-140,700
-46% -$6.97M ﹤0.01% 2337
2014
Q1
$13.7M Buy
305,700
+159,200
+109% +$7.15M 0.01% 1659
2013
Q4
$6.9M Sell
146,500
-406,900
-74% -$20.6M ﹤0.01% 2496
2013
Q3
$29.2M Buy
553,400
+385,300
+229% +$18.7M 0.02% 931
2013
Q2
$7.59M Buy
+168,100
New +$7.98M ﹤0.01% 2123

Other funds holding RMD

Susquehanna International Group's RMD Position: Q1 2026 in Review

Susquehanna International Group reduced its ResMed (RMD) stake by 11% in Q1 2026, selling an estimated $1.21M and leaving 38,172 shares worth $8.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

Susquehanna International Group first reported a position in RMD in Q2 2013 and has held it in 47 quarters since. The position peaked at $32.5M in Q1 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Susquehanna International Group held 38,172 shares of ResMed worth $8.57M as of Q1 2026.
  • Susquehanna International Group sold 4,837 ResMed shares in Q1 2026, an estimated $1.21M.
  • ResMed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3344 holding.
  • Susquehanna International Group first reported a position in ResMed in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's ResMed position peaked at $32.5M in Q1 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.